Abstract
Background: Anemia is a common condition among pregnant women and can have adverse effects on both maternal and fetal health. The use of antianemic drugs in pregnancy is essential to manage and treat anemia, but their efficacy and safety remain a topic of significant interest and concern. Objective: To study the drug use evaluation of anti anemic drugs in pregnancy patients in hospital. Cases were collected from OBG ward Methodology: A prospective observational study was conducted for three months from December 2023 to February 2024 in Navodaya medical college, hospital & research centre with a sample size of 100. Data were collected from OBG ward. Result: Among the 100 cases collected, most of the anemic patients were in the age group of (18-25) years. Most common anti anemic drugs prescribed in anemic patients are Ferrous ascorbate and Folic acid. Conclusion: in evaluation of antianemic drug use in pregnancy is essential for ensuring the effective management of maternal anemia while minimizing risks to the fetus. By assessing prescribing practices, safety considerations, and adherence to clinical guidelines, healthcare providers can enhance the quality of care provided to pregnant women and contribute to better maternal and child health outcomes
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal For Multidisciplinary Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
